Year: 2011
Type: article
Abstract: In this issue of Blood , Castellino and colleagues investigate morbidity and mortality in a cohort of long-term survivors of Hodgkin lymphoma (HL) from the Childhood Cancer Survivor Study. They observe frequent and serious late sequelae of therapy occurring even after 20 years of follow-up; their findings highlight the need to consider long-term implications when selecting therapeutic strategies for young patients with curable lymphomas.
Source: Blood
Authors: Kieron Dunleavy, Catherine M. Bollard
Institutions: Baylor College of Medicine, National Cancer Institute
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Cancer Institute
Award: SPORE in Lymphoma
OpenAlex ID: W2066238803
